Department of Cell and Molecular Physiology, Stritch School of medicine, Loyola University Chicago, Maywood, Illinois 60153, United States.
Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio 43210, United States.
J Chem Inf Model. 2023 Dec 11;63(23):7487-7498. doi: 10.1021/acs.jcim.3c00954. Epub 2023 Nov 28.
Calmodulin (CaM) is a universal regulatory protein that modulates numerous cellular processes by using calcium (Ca) as the signal. In smooth muscle cells (SMC), one major target of CaM is myosin light chain kinase (MLCK), a kinase that phosphorylates the myosin regulatory light chain and thereby regulates cell contraction. In the absence of CaM, MLCK remains inhibited by its autoinhibitory domain (AID). While it is well established that CaM activates MLCK, the molecular interactions between these two proteins remain elusive due to the lack of structural data. In this work, we constructed a molecular model of mammalian CaM (mCaM) in complex with MLCK leveraging AlphaFold, published biochemical data, and protein-protein docking. The model, along with a strategic set of CaM mutants including a inhibitory variant soybean CaM isoform 4 (sCaM-4), was subject to molecular dynamics (MD) simulations. Using principal component analysis (PCA), we mapped out the transition path for the removal of the AID from the MLCK kinase domain to provide molecular basis of MLCK activation. Additionally we established MLCK conformations that correspond to the active and inactive states of the kinase. We showed that mCaM and sCaM-4 cause MLCK to undergo the transition to the active and inactive states, respectively. Using two structural metrics, we computed the probabilities of MLCK activation by different CaM variants, which were in good agreement with the experimental data. Distributions along these metrics revealed that different inhibitory CaM variants impair MLCK activation through unique mechanisms. We finally identified molecular contacts that contribute to the MLCK activation by CaM. Overall, we report a molecular model of CaM-MLCK that provides insights into the molecular mechanism of MLCK activation by CaM. The mechanism requires effective removal of the AID while preserving an active configuration of the kinase domain. This mechanism may be shared by other MLCK isoforms and potentially other structurally similar kinases with CaM-mediated regulatory domains.
钙调蛋白 (CaM) 是一种通用的调节蛋白,通过使用钙 (Ca) 作为信号来调节许多细胞过程。在平滑肌细胞 (SMC) 中,CaM 的一个主要靶标是肌球蛋白轻链激酶 (MLCK),它是一种使肌球蛋白调节轻链磷酸化的激酶,从而调节细胞收缩。在没有 CaM 的情况下,MLCK 仍然受到其自动抑制结构域 (AID) 的抑制。虽然已经证实 CaM 激活了 MLCK,但由于缺乏结构数据,这两种蛋白质之间的分子相互作用仍然难以捉摸。在这项工作中,我们利用 AlphaFold、已发表的生化数据和蛋白质-蛋白质对接构建了哺乳动物 CaM (mCaM) 与 MLCK 复合物的分子模型。该模型,以及一组包括抑制性大豆 CaM 同工型 4 (sCaM-4) 的 CaM 突变体,进行了分子动力学 (MD) 模拟。通过主成分分析 (PCA),我们绘制了 AID 从 MLCK 激酶结构域去除的过渡路径,为 MLCK 激活提供了分子基础。此外,我们确定了与激酶的活性和非活性状态相对应的 MLCK 构象。我们表明,mCaM 和 sCaM-4 分别导致 MLCK 向活性和非活性状态转变。使用两种结构度量标准,我们计算了不同 CaM 变体引起 MLCK 激活的概率,这与实验数据非常吻合。沿着这些度量标准的分布表明,不同的抑制性 CaM 变体通过独特的机制损害 MLCK 激活。我们最终确定了有助于 CaM 激活 MLCK 的分子接触。总的来说,我们报告了一个 CaM-MLCK 的分子模型,该模型深入了解了 CaM 激活 MLCK 的分子机制。该机制需要有效地去除 AID,同时保持激酶结构域的活性构象。这种机制可能被其他 MLCK 同工型和潜在的其他具有 CaM 介导的调节结构域的结构相似激酶共享。
J Chem Inf Model. 2023-12-11
Arch Biochem Biophys. 1996-8-1
Am J Physiol Cell Physiol. 2008-8
Proc Natl Acad Sci U S A. 2004-4-20
Bioengineering (Basel). 2025-6-30
Front Endocrinol (Lausanne). 2025-6-25
Front Pharmacol. 2025-5-30
Cell Biochem Biophys. 2025-3-16
J Clin Med. 2021-3-2
Front Pharmacol. 2017-5-23